News

Munich, June 22, 2021 – The private investment company DRS Investment GmbH sells 100 percent of the shares in the Swiss software company XELOG AG to proLogistik Holding in Dortmund. XELOG will remain an independent company and bundles its resources and competencies in the field of warehouse management systems (WMS) with proLogistik and Dataphone forming the proLogistik Group.

Since the 2018 acquisition of XELOG AG by DRS from the founders Armin Töngi and Peter Duss, XELOG AG has successfully developed under the leadership of Carsten Pauli. By investing in product development, the location in Germany and marketing & sales, the foundation for future growth has been laid.

The sale to a strategic buyer with the vision of establishing a pan-European logistics network creates opportunities for XELOG to realize synergies within the proLogistik Group and to expand to other European countries. At the same time, XELOG's customers can benefit from the products and services of the entire proLogistik Group.

"We are convinced that we found the right partner for the next growth phase of XELOG", says Dr. Andreas Spiegel, Founder and Managing Partner of DRS Investment. Managing Director Carsten Pauli adds: "The new group has a broader range of logistics services and competence network compared to XELOG. I am pleased that we can make the additional capabilities available to our customers. This will also enable XELOG to focus on and further expand our core competencies of developing software-related solutions and their pragmatic application for the customer. The international strength of the group also enables us to drive the internationalization of our solutions without neglecting the focus on our Swiss home market."

By acquiring further providers of software companies along the supply chain, the proLogistik Group aims to become the European market leader. The goal is to build a group that will offer products and services along the entire supply chain from a single source in the future.

The transaction was led by DRS founder and Managing Partner Dr. Andreas Spiegel. The parties agreed not to disclose the purchase price.